Announcements
Removal of Component(s) – CELG
November 18, 2019
11/18/2019
Effective at the market close on Wednesday, November 20, 2019, CELG will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights.
- On January 3, 2019, Celgene Corporation (CELG) announced that it will be acquired by Bristol-Myers Squibb Company for $50.00 per share in cash, one share of BMY and one CVR for each share of CELG.
